Advertisement
Screener

Grace Therapeutics, Inc. (GRCE) Increase Decrease Through Transactions With Owners

2.8 / 5 stars · 68/120 Roast Me

Grace Therapeutics, Inc. Increase Decrease Through Transactions With Owners

Grace Therapeutics, Inc. (GRCE) reported Increase Decrease Through Transactions With Owners of CAD 57.30 million for the 12-month period ending 2019-03-31, per its 20-F filed 2019-06-26.

Discontinued › Notes

ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners · last filed 2019-06-26

Period endIncrease Decrease Through Transactions With Owners 1 monthIncrease Decrease Through Transactions With Owners 12 monthIncrease Decrease Through Transactions With Owners 13 month
2019-03-3157.30M CAD
20-F · filed 2019-06-26
2018-03-318.03M CAD
20-F · filed 2019-06-26
2017-03-3186.00K CAD
20-F · filed 2019-06-26
5.73M CAD
20-F · filed 2019-06-26
2017-02-285.64M CAD
20-F · filed 2019-06-26
2016-02-29309.00K CAD
20-F · filed 2018-06-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
PDS Biotechnology Corp (PDSB)United States$0.045B
SCYNEXIS INC (SCYX)United States$0.045B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
VERU INC. (VERU)United States$0.043B-3.93
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Lite Strategy, Inc. (LITS)United States$0.049B
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Kairos Pharma, LTD. (KAPA)United States$0.041B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98